GHK-Cu (Copper(II) glycyl-L-histidyl-L-lysine complex) is a synthetic copper-binding tripeptide supplied for qualified laboratory research use
Patients in major metropolitan areas including Los Angeles, New York, Houston, and Miami, where concierge medicine, functional medicine, and sports medicine clinics frequently offer cutting-edge supplements and unapproved therapies, are most likely to be targeted with marketing for these compounds once they become more accessible through regulated channels
Take advantage of the facials and the wonderful people who work here
Standardized dosing has not been firmly established in randomized trials, and what is available in compounding pharmacies reflects clinical convention more than regulatory consensus
There are different formulations, each with unique benefits and purposes